Tofacitinib, An Oral Janus Kinase Inhibitor: Safety Comparison In Patients With Rheumatoid Arthritis and An Inadequate Response To Nonbiologic Or Biologic Disease-Modifying Anti-Rheumatic Drugs
作者
GR Burmester,Christina Charles‐Schoeman,John D. Isaacs,Thijs Hendrikx,K. Y. Kwok,S.H. Zwillich,Richard J. Riese